Baker Avenue Asset Management LP boosted its stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 64.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 47,056 shares of the company's stock after purchasing an additional 18,481 shares during the period. Baker Avenue Asset Management LP's holdings in Docusign were worth $3,830,000 at the end of the most recent reporting period.
A number of other large investors also recently bought and sold shares of the stock. FMR LLC lifted its holdings in shares of Docusign by 178.2% during the 4th quarter. FMR LLC now owns 6,101,024 shares of the company's stock valued at $548,726,000 after acquiring an additional 3,908,139 shares in the last quarter. Invesco Ltd. lifted its holdings in shares of Docusign by 283.9% during the 4th quarter. Invesco Ltd. now owns 3,447,275 shares of the company's stock valued at $310,048,000 after acquiring an additional 2,549,310 shares in the last quarter. Jericho Capital Asset Management L.P. lifted its holdings in shares of Docusign by 34.0% during the 4th quarter. Jericho Capital Asset Management L.P. now owns 4,754,753 shares of the company's stock valued at $427,642,000 after acquiring an additional 1,205,500 shares in the last quarter. Pacer Advisors Inc. lifted its holdings in shares of Docusign by 809.6% during the 1st quarter. Pacer Advisors Inc. now owns 1,167,290 shares of the company's stock valued at $95,017,000 after acquiring an additional 1,038,962 shares in the last quarter. Finally, Northern Trust Corp increased its stake in Docusign by 77.2% during the 4th quarter. Northern Trust Corp now owns 1,984,378 shares of the company's stock worth $178,475,000 after buying an additional 864,408 shares during the period. Hedge funds and other institutional investors own 77.64% of the company's stock.
Insider Activity at Docusign
In other news, CFO Blake Jeffrey Grayson sold 15,143 shares of the firm's stock in a transaction dated Wednesday, June 18th. The shares were sold at an average price of $74.80, for a total transaction of $1,132,696.40. Following the completion of the transaction, the chief financial officer directly owned 110,723 shares of the company's stock, valued at approximately $8,282,080.40. This trade represents a 12.03% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Teresa Briggs sold 534 shares of the stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $74.37, for a total transaction of $39,713.58. Following the sale, the director owned 8,805 shares of the company's stock, valued at $654,827.85. This trade represents a 5.72% decrease in their position. The disclosure for this sale can be found here. Insiders sold 78,552 shares of company stock valued at $5,983,631 in the last quarter. Company insiders own 1.66% of the company's stock.
Wall Street Analysts Forecast Growth
Several research firms have recently weighed in on DOCU. Wall Street Zen downgraded shares of Docusign from a "buy" rating to a "hold" rating in a research report on Saturday. Needham & Company LLC reissued a "hold" rating on shares of Docusign in a report on Friday, June 6th. Wells Fargo & Company raised shares of Docusign from an "underweight" rating to an "equal weight" rating and upped their price target for the stock from $67.00 to $80.00 in a research note on Friday, June 13th. Bank of America cut their target price on shares of Docusign from $88.00 to $85.00 and set a "neutral" rating for the company in a research note on Friday, June 6th. Finally, Citigroup cut their target price on shares of Docusign from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Monday, June 9th. Thirteen analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $89.77.
Read Our Latest Analysis on DOCU
Docusign Price Performance
Shares of NASDAQ DOCU traded up $1.54 during trading hours on Monday, hitting $75.38. 1,362,302 shares of the stock were exchanged, compared to its average volume of 2,181,801. Docusign Inc. has a one year low of $48.80 and a one year high of $107.86. The company's 50 day moving average is $79.18 and its 200 day moving average is $82.54. The firm has a market capitalization of $15.23 billion, a P/E ratio of 14.25, a P/E/G ratio of 27.56 and a beta of 1.01.
Docusign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings results on Thursday, June 5th. The company reported $0.90 earnings per share for the quarter, beating analysts' consensus estimates of $0.81 by $0.09. Docusign had a net margin of 36.50% and a return on equity of 14.27%. The firm had revenue of $763.65 million during the quarter, compared to the consensus estimate of $748.79 million. During the same period in the prior year, the firm earned $0.82 EPS. The business's revenue was up 7.6% on a year-over-year basis. Research analysts anticipate that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.
Docusign declared that its Board of Directors has initiated a stock repurchase plan on Thursday, June 5th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the company to purchase up to 6.6% of its shares through open market purchases. Shares buyback plans are often a sign that the company's leadership believes its stock is undervalued.
About Docusign
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories

Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report